Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Boehringer Ingelheim
Express Scripts
Johnson and Johnson
Moodys

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR BETAINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Betaine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00152815 ↗ Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions Terminated Ontario HIV Treatment Network Phase 2 2003-10-01 The purpose of this study is to evaluate the effect of a one-year nutritional intervention with either betaine or vitamin E supplementation, or a weight reducing diet and exercise program on liver steatosis and steatohepatitis.
NCT00152815 ↗ Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions Terminated Johane Allard Phase 2 2003-10-01 The purpose of this study is to evaluate the effect of a one-year nutritional intervention with either betaine or vitamin E supplementation, or a weight reducing diet and exercise program on liver steatosis and steatohepatitis.
NCT00226356 ↗ Natural Supplements for Unipolar Depression Completed National Alliance for Research on Schizophrenia and Depression Phase 4 2004-12-01 This study is being conducted to determine the clinical response rate for the regimen of L-methionine, betaine and folate for unipolar depression.
NCT00226356 ↗ Natural Supplements for Unipolar Depression Completed Cambridge Health Alliance Phase 4 2004-12-01 This study is being conducted to determine the clinical response rate for the regimen of L-methionine, betaine and folate for unipolar depression.
NCT00283387 ↗ Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Phase 2 2007-02-01 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00283387 ↗ Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed Orphan Europe Phase 2 2007-02-01 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00283387 ↗ Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed Mayo Clinic Phase 2 2007-02-01 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Betaine Hydrochloride

Condition Name

Condition Name for Betaine Hydrochloride
Intervention Trials
Homocystinuria 3
Healthy 2
Chronic Hepatitis C 2
Unipolar Depression 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Betaine Hydrochloride
Intervention Trials
Homocystinuria 4
Hepatitis C 3
Hepatitis A 3
Hepatitis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Betaine Hydrochloride

Trials by Country

Trials by Country for Betaine Hydrochloride
Location Trials
United States 19
Canada 4
Italy 2
Greece 1
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Betaine Hydrochloride
Location Trials
California 4
Massachusetts 3
North Carolina 2
Nebraska 2
Minnesota 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Betaine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Betaine Hydrochloride
Clinical Trial Phase Trials
Phase 4 5
Phase 3 2
Phase 2/Phase 3 1
[disabled in preview] 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Betaine Hydrochloride
Clinical Trial Phase Trials
Completed 20
Terminated 2
Unknown status 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Betaine Hydrochloride

Sponsor Name

Sponsor Name for Betaine Hydrochloride
Sponsor Trials
University of California, San Francisco 3
McGill University Health Center 2
Mayo Clinic 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Betaine Hydrochloride
Sponsor Trials
Other 46
Industry 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
McKesson
Johnson and Johnson
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.